Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CARMN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
WNT6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PRSS12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PADI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM185A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNC1H1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CADM3-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF257 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C9orf16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00473 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOVA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNCAIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAPLN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on